BALIAS Trademark

Trademark Overview


On Friday, January 22, 2016, a trademark application was filed for BALIAS with the United States Patent and Trademark Office. The USPTO has given the BALIAS trademark a serial number of 86883618. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 26, 2019. This trademark is owned by Forest Laboratories, LLC. The BALIAS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma agents and decongestant formulations; sterile antibiotic ointments; ocular contact lens wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lightener lotions and creams; Oral, transdermal, injectable...
balias

General Information


Serial Number86883618
Word MarkBALIAS
Filing DateFriday, January 22, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 26, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 31, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma agents and decongestant formulations; sterile antibiotic ointments; ocular contact lens wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lightener lotions and creams; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing pharmaceutical preparations; Pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations and medicines for the treatment of sensory organ disorders; Pharmaceutical preparations and medicines for the treatment of central nervous system disorders; Pharmaceutical preparations and medicines for the treatment of urogenital organ disorders; Pharmaceutical preparations and medicines for the treatment of circulatory system disorders; Pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical and cosmeceutical preparations for skin care, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body
Translation of Words in MarkThe wording "BALIAS" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 28, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameALLERGAN SALES, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressMadison, NJ 07940

Party NameForest Laboratories, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054

Party NameForest Laboratories, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressParsippany, NJ 07054

Trademark Events


Event DateEvent Description
Monday, August 26, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 26, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, February 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 31, 2019EXTENSION 5 GRANTED
Tuesday, January 22, 2019EXTENSION 5 FILED
Thursday, January 31, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 22, 2019TEAS EXTENSION RECEIVED
Wednesday, August 15, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, July 19, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 17, 2018EXTENSION 4 GRANTED
Tuesday, July 17, 2018EXTENSION 4 FILED
Tuesday, July 17, 2018TEAS EXTENSION RECEIVED
Tuesday, January 16, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 12, 2018EXTENSION 3 GRANTED
Friday, January 12, 2018EXTENSION 3 FILED
Friday, January 12, 2018TEAS EXTENSION RECEIVED
Thursday, June 15, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 13, 2017EXTENSION 2 GRANTED
Tuesday, June 13, 2017EXTENSION 2 FILED
Tuesday, June 13, 2017TEAS EXTENSION RECEIVED
Saturday, January 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 5, 2017EXTENSION 1 GRANTED
Thursday, January 5, 2017EXTENSION 1 FILED
Thursday, January 5, 2017TEAS EXTENSION RECEIVED
Tuesday, July 26, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 31, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2016PUBLISHED FOR OPPOSITION
Wednesday, May 11, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 26, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 19, 2016ASSIGNED TO LIE
Saturday, April 2, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 1, 2016EXAMINER'S AMENDMENT ENTERED
Friday, April 1, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 1, 2016EXAMINERS AMENDMENT E-MAILED
Friday, April 1, 2016EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 29, 2016ASSIGNED TO EXAMINER
Thursday, January 28, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 26, 2016NEW APPLICATION ENTERED IN TRAM